ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹217 Cr | ₹205 Cr | ₹189 Cr | ₹181 Cr | ₹135 Cr |
What is the latest Total Current Liabilities ratio of ALBERT DAVID ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹217 Cr |
| Mar2024 | ₹205 Cr |
| Mar2023 | ₹189 Cr |
| Mar2022 | ₹181 Cr |
| Mar2021 | ₹135 Cr |
How is Total Current Liabilities of ALBERT DAVID Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹217 Cr | 5.80 | |
| Mar2024 | ₹205 Cr | 8.82 | |
| Mar2023 | ₹189 Cr | 4.19 | |
| Mar2022 | ₹181 Cr | 33.92 | |
| Mar2021 | ₹135 Cr | - | |
Compare Total Current Liabilities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹411.5 Cr | 2.5% | -4.6% | -12.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,926.0 Cr | -1.2% | -2.3% | 5.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,062.0 Cr | -1% | -0.9% | -0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,806.0 Cr | -1.3% | 1.4% | 38.1% | Stock Analytics | |
| CIPLA | ₹112,910.0 Cr | -0.1% | 4.8% | -6.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,755.0 Cr | -2.8% | -0.3% | 1.2% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | 2.5% |
-4.6% |
-12.7% |
| SENSEX | -2% |
-3.8% |
-8.6% |
You may also like the below Video Courses